| abstract |
The present invention relates to the compound or its pharmacological-acceptable salt that are represented by formula [I], and relate to its purposes as PDE10 inhibitor:n wherein, Rn 1 for hydrogen, halogen, low alkyl group or cyano group; Ring A is the optional heterocyclic group replaced; Ring B is optional 3 to the 6 yuan of monocyclic groups replaced; Be amino, optional aliphatic series 3 to 6 yuan of monocycle base oxygen bases, the optional low alkyl group that replaces or the optional low alkyl group-O-replaced replaced of optional amino, the optional ring replaced replaced with Y. |